Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G001 Topical Gel in Knee Osteoarthritis
NCT05007808Phase 2Completed
- Sponsor
- BUZZZ Pharmaceuticals Limited
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib topical in osteoarthritis (OA), sponsored by BUZZZ Pharmaceuticals Limited. Started Jan 2021; status: completed.
02
Drugs
celecoxib topical
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05007808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007808.